| Income Statement | 2025-09-30 | 2025-06-30 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|
| Total other income | 4,037 | 6,871 | 7,047 | 4,658 |
| Loss before provision for income taxes | -28,205 | 36,997 | -34,438 | -37,079 |
| (benefit from) provision for income taxes | -733 | 2,459 | 1,315 | 818 |
| Net loss | -27,472 | 34,538 | -35,753 | -37,897 |
| Net loss per share, basic (in dollars per share) | -0.22 | 0.28 | -0.3 | -0.32 |
| Net loss per share, diluted (in dollars per share) | -0.22 | 0.28 | -0.3 | -0.32 |
| Weighted-average shares used to compute net loss per share, basic (in shares) | 125,502,291 | 123,755,409 | 120,733,030 | 120,066,972 |
| Weighted-average shares used to compute net loss per share, diluted (in shares) | 125,502,291 | 124,509,720 | 120,733,030 | 120,066,972 |
10x Genomics, Inc. (TXG)
10x Genomics, Inc. (TXG)